August 04, 2020 - Premier Inc. (Charlotte, NC), through its ProvideGx program, has partnered with Somerset Pharma, LLC., to supply sulfamethoxazole/trimethoprim, an antibiotic combination used to treat respiratory infections, a common complication associated with COVID-19. Somerset is a new market entrant for this drug, working to creating a viable, competitive alternative … [Read more...]
Kodak announces pandemic plan to start making pharmaceutical ingredients
July 28, 2020 - Eastman Kodak Co. (Rochester, NY) received a $765 million loan from the Trump administration under the Defense Production Act, the first of its kind. The loan will be used to launch a business that will make pharmaceutical ingredients to help expedite domestic production of drugs that can treat a variety of medical conditions with the express aim of loosening … [Read more...]
Inmar Intelligence receives Innovative Technology contract from Vizient for MedEx TraySafe
Inmar Intelligence announced its MedEx TraySafe received an Innovative Technology contract from Vizient, Inc (Irving, TX). The next-generation tray and kit replenishment solution, TraySafe, can be deployed via the cloud, virtual machines, or locally hosted, and ensures trays and crash carts are correctly configured with all materials in the correct location in the tray … [Read more...]
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
Roche (Basel, Switzerland) and Blueprint Medicines Corporation announced the signing of a licensing and collaboration agreement providing exclusive rights to Roche for global co-development and commercialization outside the U.S., excluding Greater China. In the U.S., Genentech, a member of the Roche Group, will obtain co-commercialization rights to pralsetinib, Blueprint … [Read more...]
Premier Inc. ProvideGx program partners with Fresenius Kabi to supply sedation drug essential for COVID-19 care
Premier Inc. (Charlotte, NC) through its ProvideGx program, has partnered with Fresenius Kabi to supply Diprivan (propofol) injectable emulsion, USP to healthcare providers, helping to stabilize the long-term supply of a medication vital for COVID-19 patient care. Diprivan is indicated for anesthesia and sedation, including for patients who require sedation during … [Read more...]
XPOVIO (selinexor), FDA approved for treatment of relapsed or refractory diffuse large B-cell Lymphoma (DLBCL), available at Biologics by McKesson
Biologics by McKesson, an independent specialty pharmacy specializing in oncology, rare diseases and other complex therapeutic areas, was selected by Karyopharm Therapeutics, Inc. as a specialty pharmacy provider for XPOVIO (selinexor) for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (RR DLBCL), not otherwise specified, including … [Read more...]
Premier Inc.: Closing the Gap Between Drugs Purchased and Drugs Charged
From the Premier Inc. blog: "Health systems concerned about the financial impact of COVID-19 are strategizing recovery options that may include rapid margin improvement or a shift toward more value-based payment models. Key to recovery will be tactics that do not just reduce expenses, but also grow revenue.A health system’s pharmacy is ripe with these types of opportunities. … [Read more...]
Vizient updates Essential Medications list with 12 additional drugs
Vizient, Inc. (Irving, TX) announced 12 additional drugs have been added to its essential medications list whose absence would threaten hospitals’ ability to provide high quality, timely patient care. The newly added drugs are: acetaminophenammonulclobazamcoppererythromycinglucarpidaseibuprofenindomethacinlevetiracetamseleniumtobramycinzinc Vizient has now designated … [Read more...]